JohnPegramFordMD

Oncology • Sayre, PA

Hematologic Oncology

Physician

Join to view full profile

Are you Dr. Ford?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Connect with colleagues in the same hospital or clinic
You already have 74 invites waiting!
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Office
1 Guthrie Sq
Sayre, PA 18840
Phone+1 570-887-2853

Fax+1 570-887-2010
Is this information wrong?

Summary

Dr. John Ford, MD is an oncologist in Sayre, Pennsylvania. He is currently licensed to practice medicine in Pennsylvania, West Virginia, and Tennessee. He is affiliated with Guthrie Robert Packer Hospital, Mount Nittany Medical Center, and Penn Highlands Huntingdon.

Education & Training

Icahn School of Medicine at Mount SinaiFellowship, Hematology and Medical Oncology, 1987 - 1989
University of Michigan Health SystemResidency, Internal Medicine, 1974 - 1976
Columbia University Vagelos College of Physicians and SurgeonsClass of 1974

Certifications & Licensure

NY State Medical License 1976 - 2025
PA State Medical License 1993 - 2024
WV State Medical License 2018 - 2020
TN State Medical License 1998 - 2003
VA State Medical License 1998 - 2002
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Clinical Trials

Radiation Therapy (WBI Versus PBI) in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer Start of enrollment: 2005 Mar 01
Completed
Not Applicable
Capecitabine and Lapatinib Ditosylate With or Without Cixutumumab in Treating Patients With Previously Treated HER2-Positive Stage IIIB-IV Breast Cancer Start of enrollment: 2008 Jul 30
Completed
Phase 2
Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy Start of enrollment: 2008 Nov 10
Active, not recruiting
Phase 3
S0819: Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer Start of enrollment: 2009 Jul 15
Terminated
Phase 3
Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery Start of enrollment: 2010 Jun 01
Active, not recruiting
Phase 3
Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer Start of enrollment: 2011 Jan 06
Active, not recruiting
Phase 3
Join now to see all

Publications & Presentations

PubMed

1 citations
The impact of telehealth on nursing care in the radiation oncology setting during the COVID-19 pandemic.
Angela Adames, Pauline Briody, Sophia Brown, John Ford, Cori Tolda, Margaret Barton-Burke> ;Asia-Pacific Journal of Oncology Nursing. 2023 Feb 1
7 citations
Development and Pilot Implementation of a Remote Monitoring System for Acute Toxicity Using Electronic Patient-Reported Outcomes for Patients Undergoing Radiation Ther...
Kaitlyn Lapen, C. Sabol, Amy Tin, Kathleen Lynch, Alyse Kassa, Xiaolin Mabli, John Ford, Elaine Cha, Michael B. Bernstein, Lior Z. Braunstein, Oren Cahlon, Bobby Daly,...> ;International Journal of Radiation Oncology, Biology, Physics. 2021 Jul 24
1 citations
Differential nucleobase protection against 5-fluorouracil toxicity for squamous and columnar cells: implication for tissue function and oncogenesis.
John P. Vanden Heuvel, Jerry T. Thompson, Prajakta Albrecht, Donald Mandetta, Harry Kamerow, John P. Ford> ;Investigational New Drugs. 2015 Jul 1

Hospital Affiliations

Mount Nittany Medical CenterState College, Pennsylvania
Guthrie Robert Packer HospitalSayre, Pennsylvania
Saint Vincent HospitalErie, Pennsylvania
Penn Highlands HuntingdonHuntingdon, Pennsylvania